Trial lock

This content requires an active subscription.

Contact one of our representatives for assistance.

Speak With A Representative
or Call: 1-888-670-8889 (US) or 1-844-618-3192 (CAN)

Benchmarking Reports

Industry-specific benchmarking reports built on years of in-depth industry data, collected using our innovative diagnostic programs. We aggregate the data across hundreds of IT departments in your industry to give you tailored vertical insights, all packaged in professional boardroom-ready reports.

Benchmarking report example
Reference Architecture Sample Slide

Pharma & Bio-Tech Reference Architecture

Reference architectures built on years of industry expertise, honed by analysts working with real IT professionals in your industry. Leverage industry best practices so you don’t waste time and money reinventing the wheel.

Pharma & Bio-Tech Research Notes

Short, tailored research notes aimed at providing you with timely insights, relevant to your industry. Hot off the press, these notes will be published regularly and pair great with your morning coffee.

Know the Vital Signs of a Strong Data Protection Program

Date published:

April 12, 2018

Author

  • Celine Gravelines

The biotech and pharmaceutical industry deals with vast amounts of highly sensitive data – from intellectual property of new medical devices and product formulas to personal health information, such as clinical and drug medical trials. Data protection is key for players in this industry to sustain their competitive advantage and reputation.

Crowdsourcing Bridges the Gap Between Your Challenge and Artificial Intelligence

Date published:

May 15, 2017

Author

  • David Lee

Could the wisdom of the lay crowd possibly measure up to the judgment of skilled faculty surgeons? Find out how a healthcare technology company leverages “artificial artificial intelligence” and what this means for biotech IT.

Seed to Sale: Challenges in Deploying Software in the Marijuana Industry

Date published:

May 11, 2017

Author

  • Joel Martin

The legalization of marijuana is creating massive disruption for both public sector regulatory agencies and an emerging software industry. There is opportunity to apply technology in new and innovative ways as the industry continues to define and redefine itself.